Analytical Data
-
基因名
UQCR
- Application
-
别名
UQCR;Cytochrome b-c1 complex subunit 2. mitochondrial
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O14957
-
表达区间
1-56aa
-
氨基酸序列
MVTRFLGPRYRELVKNWVPTAYTWGAVGAVGLVWATDWRLILDWVPYINGKFKKDN
-
分子量
33.6kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UQCR (Ubiquinone Cytocrome c Reductase) is a crucial enzyme in the mitochondrial respiratory chain, specifically involved in the electron transfer process of oxidative phosphorylation. Its primary role is to facilitate the reduction of ubiquinone to ubiquinol, which is a vital step in energy production within eukaryotic cells. The study of UQCR recombined protein is critical for understanding mitochondrial function, as deficiencies or mutations in this enzyme can lead to a range of mitochondrial disorders, impacting cellular energy metabolism and contributing to various pathologies, including neurodegenerative diseases and heart conditions. Recent advances in recombinant DNA technology have enabled researchers to produce UQCR in a controlled laboratory setting, allowing for detailed structural and functional analysis. By studying this recombinant protein, scientists aim to elucidate its mechanisms of action, identify potential therapeutic targets, and explore its role in mitochondrial bioenergetics. Research on UQCR also encompasses its interactions with other mitochondrial proteins and its involvement in the regulation of reactive oxygen species, further highlighting its significance in maintaining mitochondrial integrity and function. Ultimately, the understanding gained from UQCR recombinant protein studies has implications for developing treatments for mitochondrial diseases and enhancing overall mitochondrial health.












